{{Rsnum
|rsid=1591830
|Chromosome=6
|position=150330764
|Orientation=plus
|GMAF=0.477
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 6.3 | 43.2 | 50.5
| HCB | 24.8 | 58.4 | 16.8
| JPT | 32.7 | 51.3 | 15.9
| YRI | 55.1 | 40.1 | 4.8
| ASW | 36.8 | 43.9 | 19.3
| CHB | 24.8 | 58.4 | 16.8
| CHD | 34.9 | 45.0 | 20.2
| GIH | 20.8 | 49.5 | 29.7
| LWK | 58.2 | 39.1 | 2.7
| MEX | 25.9 | 46.6 | 27.6
| MKK | 46.2 | 40.4 | 13.5
| TSI | 13.7 | 47.1 | 39.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19043545
|Trait=Serum metabolites
|Title=Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum
|RiskAllele=
|Pval=1E-7
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs1591830
|Name_s=
|Gene_s=RNU4P1
|Feature=
|Evidence=PubMed ID:19043545; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum. (Initial Sample Size: 284 males; Replication Sample Size: NR); (Region: 6q25.1; Reported Gene(s): C6orf71; Risk Allele: rs1591830-?); (p-value= 0.0000001).This variant is associated with Serum metabolites.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740310
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1591830
|overall_frequency_n=62
|overall_frequency_d=128
|overall_frequency=0.484375
|n_genomes=40
|n_genomes_annotated=0
|n_haplomes=56
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | Affy GenomeWide 6}}